1. Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis. Issue 5 (22nd June 2017) Authors: Kenet, G.; Oladapo, A.; Epstein, J.D.; Thompson, C.; Novack, A.; Nugent, D. J. Journal: Haemophilia Issue: Volume 23:Issue 5(2017) Page Start: e394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗